Avenue Therapeutics, Inc. · OTC:ATXI

Fortress Biotech, Inc. reported a 13.40% stake in Avenue Therapeutics, Inc. (Schedule 13D/A)

Event Jan 2, 2026 · Filed Jan 6, 2026

Fortress Biotech, Inc. reported a 13.40% stake in Avenue Therapeutics, Inc., 439,955 shares, with active intent on Jan 2, 2026. Filed Jan 6, 2026 (Schedule 13D/A).

Stake
13.40%
Shares
439,955
Intent
Active
What changed
Stake changed

The filing in full

HolderStakeShares
Fortress Biotech, Inc.13.40%439,955

Source

View original at SEC

Related